The obsession with reducing public spending on prescription drugs, which takes the form of constantly falling price caps, bulk purchasing strategies and reimbursement restrictions, entails numerous unintended consequences, especially for the health of Canadians. These are the findings of a new study from the Montreal Economic Institute (MEI).

Media release :: Government monopoly would reduce the quality of prescription drug coverage

A new national drug plan.

A new national drug plan.

Regulations on tourist accommodation establishments.

A global and non-coercive approach to fighting obesity.

Supply management in dairy farming.

The impact of ill-conceived regulations.

In recent years, we have witnessed the emergence of groups that, in the name of public health, seek greater government supervision over our daily lives. This can take the form of taxes or regulations, as the case may be. When it comes to the phenomenon of obesity, the Research Paper by Dr. David Gratzer, in collaboration with Jasmin Guénette, suggests a positive approach that takes account of the complexity of the problem rather than turning to a tax on specific products, a route that has failed to deliver the hoped-for results, as explained in a previous MEI Economic Note.

A global and non-coercive approach to fighting obesity.

A global and non-coercive approach to fighting obesity.